Status:
COMPLETED
Prostaglandin Analog Eyelash Serum and Ocular Surface Health: A Prospective Study
Lead Sponsor:
University of Seville
Conditions:
Dry Eye
Eligibility:
FEMALE
18-30 years
Phase:
NA
Brief Summary
This prospective interventional study investigates the effects of a prostaglandin analog-based eyelash serum on ocular surface integrity, tear film stability, and eyelash growth over six weeks. Ninete...
Eligibility Criteria
Inclusion
- Female individuals aged 18 to 30 years.
- Corrected distance visual acuity (CDVA) of 0.10 LogMAR or better in both eyes.
- Fitzpatrick skin type III or lower.
- No active dermatological conditions affecting the periocular area.
- Regular use of cosmetic products (e.g., mascara, eyeliner, or eyeshadow) with no history of intolerance.
- Willingness and ability to follow the serum application protocol for six weeks.
Exclusion
- History or diagnosis of dry eye disease or other ocular surface disorders.
- Previous ocular surgery, trauma, or systemic conditions affecting ocular surface function.
- Use of topical or systemic medications that could impact tear film stability.
- Documented hypersensitivity or allergic reactions to cosmetic or ophthalmic products.
- Presence of eyelid disorders that could interfere with eyelash growth (e.g., blepharitis, trichiasis).
- Use of growth-enhancing serums within the past three months.
- Pregnancy or breastfeeding at the time of enrollment.
Key Trial Info
Start Date :
January 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2025
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT06875687
Start Date
January 15 2025
End Date
February 28 2025
Last Update
March 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Seville
Seville, Spain, 41012